18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
Recruiting now
Conditions studied: Cancer, FAP
In brief
To evaluate the potential usefulness of 18F-FAPI-04 positron emission tomography/computed tomography (PET/CT) and positron emission tomography/magnetic resonance imaging （PET/MR）for the diagnosis of primary and metastatic lesions, detection of recurrence or assessment of pathologic response in various types of cancer.
Key facts
- Study ID
- NCT06557590
- Run by
- Hunan Cancer Hospital
- People needed
- 500
- Starts
- 2024-01-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2024-08-16
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
You may not qualify if…
- patients with non-malignant lesions; patients with pregnancy; the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Where it is running
- Hunan Cancer hospital — Changsha, Hunan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.